Mechanically reducing regional left ventricular wall stress and improving ejection fraction in heart failure patients

T Urgert, F.R. Halfwerk (Contributor), M. van den Heuvel (Contributor), Rob Hagmeijer (Contributor), J.G. Grandjean

    Research output: Contribution to conferenceAbstract

    Abstract

    IntroductionHeart failure with a reduced Ejection Fraction (HFrEF) is a progressive disease with a low 5-year survival of <50%, affecting 23 million people. It is characterized by adverse remodelling of the left ventricle (dilated cardiomyopathy). For every 5% increase in EF there is a 13% decrease in mortality. Pharmacological treatment and cardiac resynchronisation therapy have proven beneficial for survival. However, HFrEF still remains a progressive deadly disease. In HFrEF myocardial wall stress is increased and wall stress reduction might prevent or even reverse remodelling. Some devices, superficially constraining the dilated heart, have shown EF-increase and promote reverse remodelling. However, current devices cannot adapt to left ventricle reverse remodelling or apply different restraints to regional parts of the ventricle which limits these beneficial effects, thus limiting long-term effect of this treatment. Furthermore, regional wall stresses during a full cardiac cycle in humans are unknown.AimWe aim to develop a device to reduce left ventricular regional wall stresses, prevent further dilatation, increase the ejection fraction and guide reverse remodelling.MethodsFirst, we will measure wall stresses during the full cardiac cycle. Next, we will develop a simplified mathematical model of the left ventricle to characterize the weakened wall and to determine optimal material properties and configuration of a device.Using a synthetic heart model adjusted to various HFrEF stages, we will obtain wall stresses of the left ventricle constraint with smart materials in different configurations. Possible side effects on diastolic filling, pressure build-up, flow and coronary arteries will be examined.
    Original languageEnglish
    Publication statusPublished - 18 Apr 2019
    EventWetenschapsdag Medisch Spectrum Twente 2019 - Medisch Spectrum Twente, Enschede, Netherlands
    Duration: 18 Apr 201918 Apr 2019

    Conference

    ConferenceWetenschapsdag Medisch Spectrum Twente 2019
    CountryNetherlands
    CityEnschede
    Period18/04/1918/04/19

    Fingerprint

    Heart Failure
    Equipment and Supplies
    Ventricular Remodeling
    Heart Ventricles
    Cardiac Resynchronization Therapy
    Survival
    Dilated Cardiomyopathy
    Dilatation
    Coronary Vessels
    Theoretical Models
    Pharmacology
    Blood Pressure
    Mortality
    Therapeutics

    Cite this

    Urgert, T., Halfwerk, F. R., van den Heuvel, M., Hagmeijer, R., & Grandjean, J. G. (2019). Mechanically reducing regional left ventricular wall stress and improving ejection fraction in heart failure patients. Abstract from Wetenschapsdag Medisch Spectrum Twente 2019, Enschede, Netherlands.
    Urgert, T ; Halfwerk, F.R. ; van den Heuvel, M. ; Hagmeijer, Rob ; Grandjean, J.G. / Mechanically reducing regional left ventricular wall stress and improving ejection fraction in heart failure patients. Abstract from Wetenschapsdag Medisch Spectrum Twente 2019, Enschede, Netherlands.
    @conference{4f3d32bf8bd944829a9d4981df743a6d,
    title = "Mechanically reducing regional left ventricular wall stress and improving ejection fraction in heart failure patients",
    abstract = "IntroductionHeart failure with a reduced Ejection Fraction (HFrEF) is a progressive disease with a low 5-year survival of <50{\%}, affecting 23 million people. It is characterized by adverse remodelling of the left ventricle (dilated cardiomyopathy). For every 5{\%} increase in EF there is a 13{\%} decrease in mortality. Pharmacological treatment and cardiac resynchronisation therapy have proven beneficial for survival. However, HFrEF still remains a progressive deadly disease. In HFrEF myocardial wall stress is increased and wall stress reduction might prevent or even reverse remodelling. Some devices, superficially constraining the dilated heart, have shown EF-increase and promote reverse remodelling. However, current devices cannot adapt to left ventricle reverse remodelling or apply different restraints to regional parts of the ventricle which limits these beneficial effects, thus limiting long-term effect of this treatment. Furthermore, regional wall stresses during a full cardiac cycle in humans are unknown.AimWe aim to develop a device to reduce left ventricular regional wall stresses, prevent further dilatation, increase the ejection fraction and guide reverse remodelling.MethodsFirst, we will measure wall stresses during the full cardiac cycle. Next, we will develop a simplified mathematical model of the left ventricle to characterize the weakened wall and to determine optimal material properties and configuration of a device.Using a synthetic heart model adjusted to various HFrEF stages, we will obtain wall stresses of the left ventricle constraint with smart materials in different configurations. Possible side effects on diastolic filling, pressure build-up, flow and coronary arteries will be examined.",
    author = "T Urgert and F.R. Halfwerk and {van den Heuvel}, M. and Rob Hagmeijer and J.G. Grandjean",
    year = "2019",
    month = "4",
    day = "18",
    language = "English",
    note = "Wetenschapsdag Medisch Spectrum Twente 2019 ; Conference date: 18-04-2019 Through 18-04-2019",

    }

    Urgert, T, Halfwerk, FR, van den Heuvel, M, Hagmeijer, R & Grandjean, JG 2019, 'Mechanically reducing regional left ventricular wall stress and improving ejection fraction in heart failure patients' Wetenschapsdag Medisch Spectrum Twente 2019, Enschede, Netherlands, 18/04/19 - 18/04/19, .

    Mechanically reducing regional left ventricular wall stress and improving ejection fraction in heart failure patients. / Urgert, T; Halfwerk, F.R. (Contributor); van den Heuvel, M. (Contributor); Hagmeijer, Rob (Contributor); Grandjean, J.G.

    2019. Abstract from Wetenschapsdag Medisch Spectrum Twente 2019, Enschede, Netherlands.

    Research output: Contribution to conferenceAbstract

    TY - CONF

    T1 - Mechanically reducing regional left ventricular wall stress and improving ejection fraction in heart failure patients

    AU - Urgert, T

    AU - Grandjean, J.G.

    A2 - Halfwerk, F.R.

    A2 - van den Heuvel, M.

    A2 - Hagmeijer, Rob

    PY - 2019/4/18

    Y1 - 2019/4/18

    N2 - IntroductionHeart failure with a reduced Ejection Fraction (HFrEF) is a progressive disease with a low 5-year survival of <50%, affecting 23 million people. It is characterized by adverse remodelling of the left ventricle (dilated cardiomyopathy). For every 5% increase in EF there is a 13% decrease in mortality. Pharmacological treatment and cardiac resynchronisation therapy have proven beneficial for survival. However, HFrEF still remains a progressive deadly disease. In HFrEF myocardial wall stress is increased and wall stress reduction might prevent or even reverse remodelling. Some devices, superficially constraining the dilated heart, have shown EF-increase and promote reverse remodelling. However, current devices cannot adapt to left ventricle reverse remodelling or apply different restraints to regional parts of the ventricle which limits these beneficial effects, thus limiting long-term effect of this treatment. Furthermore, regional wall stresses during a full cardiac cycle in humans are unknown.AimWe aim to develop a device to reduce left ventricular regional wall stresses, prevent further dilatation, increase the ejection fraction and guide reverse remodelling.MethodsFirst, we will measure wall stresses during the full cardiac cycle. Next, we will develop a simplified mathematical model of the left ventricle to characterize the weakened wall and to determine optimal material properties and configuration of a device.Using a synthetic heart model adjusted to various HFrEF stages, we will obtain wall stresses of the left ventricle constraint with smart materials in different configurations. Possible side effects on diastolic filling, pressure build-up, flow and coronary arteries will be examined.

    AB - IntroductionHeart failure with a reduced Ejection Fraction (HFrEF) is a progressive disease with a low 5-year survival of <50%, affecting 23 million people. It is characterized by adverse remodelling of the left ventricle (dilated cardiomyopathy). For every 5% increase in EF there is a 13% decrease in mortality. Pharmacological treatment and cardiac resynchronisation therapy have proven beneficial for survival. However, HFrEF still remains a progressive deadly disease. In HFrEF myocardial wall stress is increased and wall stress reduction might prevent or even reverse remodelling. Some devices, superficially constraining the dilated heart, have shown EF-increase and promote reverse remodelling. However, current devices cannot adapt to left ventricle reverse remodelling or apply different restraints to regional parts of the ventricle which limits these beneficial effects, thus limiting long-term effect of this treatment. Furthermore, regional wall stresses during a full cardiac cycle in humans are unknown.AimWe aim to develop a device to reduce left ventricular regional wall stresses, prevent further dilatation, increase the ejection fraction and guide reverse remodelling.MethodsFirst, we will measure wall stresses during the full cardiac cycle. Next, we will develop a simplified mathematical model of the left ventricle to characterize the weakened wall and to determine optimal material properties and configuration of a device.Using a synthetic heart model adjusted to various HFrEF stages, we will obtain wall stresses of the left ventricle constraint with smart materials in different configurations. Possible side effects on diastolic filling, pressure build-up, flow and coronary arteries will be examined.

    M3 - Abstract

    ER -

    Urgert T, Halfwerk FR, van den Heuvel M, Hagmeijer R, Grandjean JG. Mechanically reducing regional left ventricular wall stress and improving ejection fraction in heart failure patients. 2019. Abstract from Wetenschapsdag Medisch Spectrum Twente 2019, Enschede, Netherlands.